Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients

Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar
doi: https://doi.org/10.1101/2021.04.06.21254949

Article Information

doi 
https://doi.org/10.1101/2021.04.06.21254949
History 
  • April 7, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Mounzer Agha1,
  2. Maggie Blake1,
  3. Charles Chilleo3,
  4. Alan Wells2 and
  5. Ghady Haidar4,*
  1. 1Hillman Cancer Center, UPMC, Pittsburgh, PA, USA
  2. 2Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  3. 3UPMC Clinical Laboratories, Pittsburgh, PA, USA
  4. 4Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  1. ↵*Correspondence
    : Ghady Haidar, MD. 3601 Fifth Ave, Falk Medical BLDG, Suite 5B. Pittsburgh, PA, 15213, USA. +1-412-648-6601. haidarg{at}upmc.edu
Back to top
Posted April 07, 2021.
Download PDF
Data/Code
Email
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar
medRxiv 2021.04.06.21254949; doi: https://doi.org/10.1101/2021.04.06.21254949
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area